United Therapeutics UTHR Ralinepag — Milestone payment to be made
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by United Therapeutics in its filing.
Tagged under the XBRL concept uthr:MilestonePaymentToBeMadeUponCommercialLaunchOfProduct.
The official record: United Therapeutics’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →
Ask your AI about United Therapeutics's ralinepag — milestone payment to be made.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is United Therapeutics's ralinepag — milestone payment to be made?
- United Therapeutics (UTHR) reported ralinepag — milestone payment to be made of $62.5M in Q4 2025.
- How has United Therapeutics's ralinepag — milestone payment to be made changed year-over-year?
- United Therapeutics's ralinepag — milestone payment to be made decreased by 0.0% year-over-year, from $62.5M to $62.5M.
- What is the long-term trend for United Therapeutics's ralinepag — milestone payment to be made?
- Over 4 years (2021 to 2025), United Therapeutics's ralinepag — milestone payment to be made has grown at a 0.0% compound annual growth rate (CAGR), from $250M to $250M.
- What does ralinepag — milestone payment to be made mean?
- This metric represents the future financial obligations associated with achieving specific development, regulatory, or commercial milestones for a pharmaceutical asset. These payments are typically triggered by the successful progression of clinical trials or the attainment of marketing authorizations. It reflects the contingent capital commitment required to advance a specific drug candidate through its lifecycle.